Latest Publications

Share:

Training Program Applications Now Open for Colorado's Natural Medicine Program

With the Approved Facilitator Training Programs (AFTP) rules in effect as of June 30, The Office of Natural Medicine Licensure (the "Office") has opened applications for AFTP. These are the first applications available under...more

Colorado's Draft Natural Medicine Rules: Full Breakdown & Commentary

Nearly fifteen months after Colorado voters approved the Natural Medicine Health Act, the public got its first glimpse of draft rules that will govern the regulated psychedelics program created by the Act. In February’s...more

Colorado Natural Medicine Advisory Bulletin #4: September 2023

Coming into the sixth month of work, Colorado’s regulated natural medicine program is starting to take shape. Answers to big-picture questions – such as what the scope of practice for a licensed facilitator is, and whether...more

Colorado Natural Medicine Health Act Tracker Produced by Vicente LLP and Psychedelic Alpha

Vicente LLP is proud to collaborate with Psychedelic Alpha—an independent newsletter and community in the field of psychedelics—on the Colorado Natural Medicine Health Act Tracker, which includes high-level statistics,...more

The Ultimate Guide to SB23-290, Colorado’s Natural Medicine Regulation and Legalization Bill

Colorado voters approved Proposition 122, the Natural Medicine Health Act (NMHA), in the 2022 general election. On May 2, 2023, the Colorado Legislature passed SB23-290, the formal implementation bill for Proposition 122....more

Colorado Psychedelics Update: Natural Medicine Health Act Implementation Bill SB23-290 Engrossed, Reengrossed, and Heading to the...

SB23-290, the formal implementation bill for the Natural Medicine Health Act, passed its third reading in the Colorado Senate on Tuesday, April 25, 2023. If passed, SB23-290 would replace Proposition 122. Since its...more

Understanding the Current Legal Status of Psychedelics in the United States

In a previous article, we explored one potential current opportunity for entrepreneurs interested in psychedelics and mycelium—producing non-psychoactive mushroom supplements. But are there any current commercial...more

Financing Adaptogenic Mushroom Companies: Seven Basic Regulatory Points to Understand

Aside from a small number of companies the FDA has permitted to pursue the development of psilocybin therapies (e.g., Compass), the majority of psychedelic mushroom sales in the U.S. currently violate both state and federal...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide